title: Cost effectiveness and delivery study for future HIV vaccines.
abstract: Research teams from five countries, Brazil, China, Kenya, Peru and Thailand, have initiated a policy-maker survey on vaccine delivery, cost studies for future HIV vaccination programmes, and associated simulation modeling exercises analysing the relative cost-effectiveness of potential HIV vaccination strategies. The survey assesses challenges and opportunities for future country-level HIV vaccination strategies, providing data on the vaccine characteristics (e.g. vaccine efficacies for susceptibility, infectiousness and disease progression) and vaccination programme strategies to be considered in the cost-effectiveness modeling analyses. The study will provide decision-makers with modeling data on vaccination policy considerations that will assist in developing country-level capacities for future HIV vaccine policy adoption and effective delivery systems, and will help delineate the long-term financial requirements for sustainable HIV vaccination programmes. The WHO-UNAIDS HIV Vaccine Initiative and the collaborating researchers welcome comments or questions from policy makers, health professionals and other stakeholders in the public and private sectors about this effort to help advance policy and capacity related to future potential HIV vaccines.
authors.affiliation: Center for Healthcare Effectiveness Research, Wayne State University School of Medicine, Detroit, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: Barth-Jones
authors.forename: H
authors.initials: H
authors.lastname: Cheng
authors.forename: L Y
authors.initials: LY
authors.lastname: Kang
authors.forename: Patrick R
authors.initials: PR
authors.lastname: Kenya
authors.forename: D
authors.initials: D
authors.lastname: Odera
authors.forename: N R
authors.initials: NR
authors.lastname: Mosqueira
authors.forename: W
authors.initials: W
authors.lastname: Mendoza
authors.forename: M C
authors.initials: MC
authors.lastname: Portela
authors.forename: C
authors.initials: C
authors.lastname: Brito
authors.forename: V
authors.initials: V
authors.lastname: Tangcharoensathien
authors.forename: C
authors.initials: C
authors.lastname: Akaleephan
authors.forename: S
authors.initials: S
authors.lastname: Supantamart
authors.forename: W
authors.initials: W
authors.lastname: Patcharanarumol
authors.forename: L F
authors.initials: LF
authors.lastname: de Macedo Brigido
authors.forename: M G P
authors.initials: MG
authors.lastname: Fonseca
authors.forename: M
authors.initials: M
authors.lastname: Sanchez
authors.forename: M-L
authors.initials: ML
authors.lastname: Chang
authors.forename: S
authors.initials: S
authors.lastname: Osmanov
authors.forename: S
authors.initials: S
authors.lastname: Avrett
authors.forename: J
authors.initials: J
authors.lastname: Esparza
authors.forename: U
authors.initials: U
authors.lastname: Griffiths
mesh_terms: D016915:AIDS Vaccines / Q000191:economics* / Q000600:supply & distribution; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care; D015658:HIV Infections / Q000191:economics / Q000517:prevention & control*; D019538:Health Care Surveys; D006291:Health Policy; D006297:Health Services Accessibility; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D007391:International Cooperation; D017059:Models, Econometric; D011050:Policy Making
chemical_list: D016915:AIDS Vaccines